253 related articles for article (PubMed ID: 36636895)
1. Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure.
Fairclough S; Goodden J; Chumas P; Mathew R; Maguire M
Epilepsia; 2023 Apr; 64(4):857-865. PubMed ID: 36636895
[TBL] [Abstract][Full Text] [Related]
2. First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsy.
van der Meer PB; Maschio M; Dirven L; Taphoorn MJB; Koekkoek JAF;
Epilepsia; 2023 Jan; 64(1):162-169. PubMed ID: 36380710
[TBL] [Abstract][Full Text] [Related]
3. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Weston J; Marson AG
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001904. PubMed ID: 30353945
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Cividini S; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD011412. PubMed ID: 35363878
[TBL] [Abstract][Full Text] [Related]
8. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001911. PubMed ID: 28240353
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD001904. PubMed ID: 27976799
[TBL] [Abstract][Full Text] [Related]
11. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
[TBL] [Abstract][Full Text] [Related]
12. Pregabalin add-on for drug-resistant focal epilepsy.
Panebianco M; Bresnahan R; Hemming K; Marson AG
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
[TBL] [Abstract][Full Text] [Related]
13. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003615. PubMed ID: 30350354
[TBL] [Abstract][Full Text] [Related]
14. Glioma features and seizure control during long-term follow-up.
Ollila L; Roivainen R
Epilepsy Behav Rep; 2023; 21():100586. PubMed ID: 36712600
[TBL] [Abstract][Full Text] [Related]
15. Patterns of antiseizure medication utilization in the Human Epilepsy Project.
Fox J; Barnard S; Agashe SH; Holmes MG; Gidal B; Klein P; Abou-Khalil BW; French J;
Epilepsia; 2023 Dec; 64(12):3196-3204. PubMed ID: 37846772
[TBL] [Abstract][Full Text] [Related]
16. Impact of seizures and antiseizure medication on survival in patients with glioma.
Kumar TS; Afnan WM; Chan CY; Audrey C; Fong SL; Rajandram R; Lim KS; Narayanan V
J Neurooncol; 2022 Sep; 159(3):657-664. PubMed ID: 36036318
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of anti-epileptic drugs in patients with gliomas and seizures.
van Breemen MS; Rijsman RM; Taphoorn MJ; Walchenbach R; Zwinkels H; Vecht CJ
J Neurol; 2009 Sep; 256(9):1519-26. PubMed ID: 19434440
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
[TBL] [Abstract][Full Text] [Related]
19. Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center.
Green SF; Hare N; Kassam M; Rugg-Gunn F; Koepp MJ; Sander JW; Rajakulendran S
Epilepsy Behav; 2022 Oct; 135():108868. PubMed ID: 35985166
[TBL] [Abstract][Full Text] [Related]
20. Non-discontinuation of antiseizure medication in seizure-free epilepsy patients.
Doerrfuss JI; Hüsing T; Graf L; Ilyas-Feldmann M; Holtkamp M
Eur J Neurol; 2024 Mar; 31(3):e16160. PubMed ID: 38015451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
